If the deal is primarily structured as a share exchange (as press reports suggest), the resulting dilution would fall squarely on the Ricards. In a scenario where Pernod absorbs Brown-Forman, the Ricard family would hold only 8.6% of the combined capital against 10.5% for the Browns, even though Pernod would represent 56.4% of the group. In a NewCo structure, the gap narrows slightly (8.9% vs 10.0%), but the direction remains the same.
The only lever capable of reversing this arithmetic is the double voting right. Pernod Ricard's bylaws provide this mechanism for any registered share held for at least ten years. In a scenario where Pernod survives as the parent under French law, the Ricard family would control 13.3% of voting rights against 9.5% for the Browns, despite holding less capital. This double voting right exists only within a French legal framework. A NewCo structure, let alone an American parent, would strip the Ricards of it and shift the centre of gravity across the Atlantic.
The market reaction captured this complexity well, proving nothing is settled : Brown-Forman surged on the announcement while the French group dropped (Pernod being Pernod) before partially recovering. For an all-stock transaction, this performance asymmetry makes the "merger of equals" framing hard to sustain. The most favourable structure for the Ricards would be a French parent absorbing Brown-Forman as an American subsidiary, preserving double voting rights while gaining a broader US listing. Any other structure, a neutral NewCo in particular, would be presented as more balanced on paper, but would amount to the Ricards surrendering their main control tool with no guarantee of getting it back.
Beyond governance, the family's financial capacity to rebuild a position in case of dilution is limited. Pernod Ricard has distributed more than its cumulative earnings over 2020-2025 between dividends and cancelled buybacks, pushing up its debt load. The family holding structure's debt could reach €1.6bn, with latent capital gains on the stake limited to €487m at current prices. The double voting right is therefore not merely a political shield, it is the only real safety net left should the deal go through.
III. Reinventing on a shrinking dance floor
Tomorrow 2 is not another cost-cutting plan dressed up with a grand name. It is the end of the "one brand, one organisation" model : two business units, Gold and Crystal, where there used to be as many as there were brands in the portfolio. The real test for the Marseille-based group will come in 18 months, not in the cost line or the announced €1bn in savings, but in the conversion of EBITDA into FCF. And that conversion is starting to show some colour : €853m in FY24, €1,066m in FY25, €1,236m expected in FY26.
The portfolio rationalisation follows the same logic. Where our 2024 Teaser counted 2 disposals against 5 acquisitions, the trend has since reversed : 7 disposals for only 3 acquisitions since our last Teaser. The group is finally shedding what was dragging it down. What remains must grow, and that is precisely where the shoe still pinches : a leaner group is not necessarily a growing one.
The harder problem is that Pernod is reinventing itself in a shrinking market. Generation Z drinks less than its predecessors, GLP-1 drugs are starting to weigh on consumption behaviours, and the premiumisation that masked flat volumes for a decade is hitting its ceiling. Pernod is restructuring against a contracting backdrop, a very different equation from 2015.
The new architecture can work, but only if it executes faster than its peers. The consumer shift is clear : aperitif is the new digestif, and large premium formats are losing ground to convenience formats. Campari saw this coming a decade ago with Aperol ; Pernod is catching up with Italicus and St~Petroni. Right direction, but Campari had a ten-year head start and the results to show for it. Pernod cannot afford to miss another step.
RTDs remain the only credible near-term growth relay, up +20% in the US while hard seltzers decline 7.4%. But let us keep perspective : 2% of North American sales today. A real growth driver, but not a meaningful earnings contributor before FY28 at the earliest.
IV. Priced for extinction, built to last
At these levels, Pernod Ricard looks more like a de-rated name than a broken one. Valuation has compressed sharply, with adjusted P/E falling from 27.8x in FY24 to 11.2x in FY26E in our model. Cash is holding up better than market sentiment suggests : pre-dividend FCF climbs from €0.85bn in FY24 to €1.06bn in FY25 and would reach €1.24bn in FY26E, implying a FCF yield of 7.6%. A dividend yield of 6.9% in FY26E further suggests that a large part of the bad news is already in the price.
The thesis ultimately rests on a simple conviction : the Ricards will not abandon ship. Three generations of building do not end in a quiet dilution inside an American NewCo. The balance sheet leaves less room than before, with Adj. Net debt/EBITDA at 3.40x in FY25 and 3.88x in FY26E, limiting flexibility if Brown-Forman would be poorly structured. However, if the family opts to preserve the French framework and the double voting right, as their entire history suggests they will, then Brown-Forman becomes a catalyst rather than a threat.
With a restructuring that was long overdue, a leaner portfolio positioned to capture the right trends, and a family whose interests remain aligned with minority shareholders over the long term, the market is pricing a centenary family business as if it were about to disappear. It is not heading that way. At this price, that is an invitation to enter.
